BECN1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Among participants with a history of viral-onset ME/CFS, changes in BECLIN-1 levels from baseline to time point 3 were positively correlated with improvements in several clinical outcomes (Fig. 5C–F).